Aromatase inhibitor (class)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Aromatase inhibitor (class), covering 2010-10-11 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.